OpenURL Connection Search

Select item for more details and to access through your institution.

The combination of ibrutinib and rituximab demonstrates activity in first‐line follicular lymphoma.
Published in:
British Journal of Haematology, 2020, v. 189, n. 4, p. 650, doi. 10.1111/bjh.16424
By:
- Fowler, Nathan H.;
- Nastoupil, Loretta;
- De Vos, Sven;
- Knapp, Mark;
- Flinn, Ian W.;
- Chen, Robert;
- Advani, Ranjana H.;
- Bhatia, Sumeet;
- Martin, Peter;
- Mena, Raul;
- Davis, Richard Eric;
- Neelapu, Sattva S.;
- Eckert, Karl;
- Ping, Jerry;
- Co, Melannie;
- Beaupre, Darrin M.;
- Neuenburg, Jutta K.;
- Palomba, M. Lia
Publication type:
Article
Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single‐agent ibrutinib in patients with chronic lymphocytic leukaemia.
Published in:
British Journal of Haematology, 2019, v. 186, n. 1, p. 184, doi. 10.1111/bjh.15791
By:
- Wierda, William G.;
- Byrd, John C.;
- O'Brien, Susan;
- Coutre, Steven;
- Barr, Paul M.;
- Furman, Richard R.;
- Kipps, Thomas J.;
- Burger, Jan A.;
- Stevens, Don A.;
- Sharman, Jeff;
- Ghia, Paolo;
- Flinn, Ian W.;
- Zhou, Cathy;
- Ninomoto, Joi;
- James, Danelle F.;
- Tam, Constantine S.
Publication type:
Article
Bendamustine, bortezomib and rituximab produces durable complete remissions in patients with previously untreated, low grade lymphoma.
Published in:
British Journal of Haematology, 2018, v. 180, n. 3, p. 365, doi. 10.1111/bjh.15044
By:
- Flinn, Ian W.;
- Thompson, Dana S.;
- Boccia, Ralph V.;
- Miletello, Gerald;
- Lipman, Andrew;
- Flora, Douglas;
- Cuevas, Daniel;
- Papish, Steven W.;
- Berdeja, Jesus G.
Publication type:
Article
Use of anticoagulants and antiplatelet in patients with chronic lymphocytic leukaemia treated with single-agent ibrutinib.
Published in:
British Journal of Haematology, 2017, v. 178, n. 2, p. 286, doi. 10.1111/bjh.14660
By:
- Jones, Jeffrey A.;
- Hillmen, Peter;
- Coutre, Steven;
- Tam, Constantine;
- Furman, Richard R.;
- Barr, Paul M.;
- Schuster, Stephen J.;
- Kipps, Thomas J.;
- Flinn, Ian W.;
- Jaeger, Ulrich;
- Burger, Jan A.;
- Cheng, Mei;
- Ninomoto, Joi;
- James, Danelle F.;
- Byrd, John C.;
- O'Brien, Susan M.
Publication type:
Article
Real-world clinical experience in the Connect<sup>®</sup> chronic lymphocytic leukaemia registry: a prospective cohort study of 1494 patients across 199 US centres.
Published in:
British Journal of Haematology, 2016, v. 175, n. 5, p. 892, doi. 10.1111/bjh.14332
By:
- Mato, Anthony;
- Nabhan, Chadi;
- Kay, Neil E.;
- Weiss, Mark A.;
- Lamanna, Nicole;
- Kipps, Thomas J.;
- Grinblatt, David L.;
- Flinn, Ian W.;
- Kozloff, Mark F.;
- Flowers, Christopher R.;
- Farber, Charles M.;
- Kiselev, Pavel;
- Swern, Arlene S.;
- Sullivan, Kristen;
- Flick, E. Dawn;
- Sharman, Jeff P.
Publication type:
Article
Otlertuzumab ( TRU-016), an anti- CD37 monospecific ADAPTIR<sup>™</sup> therapeutic protein, for relapsed or refractory NHL patients.
Published in:
British Journal of Haematology, 2015, v. 168, n. 1, p. 38, doi. 10.1111/bjh.13099
By:
- Pagel, John M.;
- Spurgeon, Stephen E.;
- Byrd, John C.;
- Awan, Farrukh T.;
- Flinn, Ian W.;
- Lanasa, Mark C.;
- Eisenfeld, Amy J.;
- Stromatt, Scott C.;
- Gopal, Ajay K.
Publication type:
Article
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
Published in:
British Journal of Haematology, 2014, v. 167, n. 4, p. 466, doi. 10.1111/bjh.13061
By:
- Awan, Farrukh T.;
- Hillmen, Peter;
- Hellmann, Andrzej;
- Robak, Tadeusz;
- Hughes, Steven G.;
- Trone, Denise;
- Shannon, Megan;
- Flinn, Ian W.;
- Byrd, John C.
Publication type:
Article
Ponatinib in patients with refractory acute myeloid leukaemia: findings from a phase 1 study.
Published in:
British Journal of Haematology, 2013, v. 162, n. 4, p. 548, doi. 10.1111/bjh.12382
By:
- Shah, Neil P.;
- Talpaz, Moshe;
- Deininger, Michael W. N.;
- Mauro, Michael J.;
- Flinn, Ian W.;
- Bixby, Dale;
- Lustgarten, Stephanie;
- Gozgit, Joseph M.;
- Clackson, Tim;
- Turner, Christopher D.;
- Haluska, Frank G.;
- Kantarjian, Hagop;
- Cortes, Jorge E.
Publication type:
Article
Safety, tolerability, and preliminary activity of IMGN529, a CD37-targeted antibody-drug conjugate, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: a dose-escalation, phase I study.
Published in:
Investigational New Drugs, 2018, v. 36, n. 5, p. 869, doi. 10.1007/s10637-018-0570-4
By:
- Stathis, Anastasios;
- Flinn, Ian W.;
- Madan, Sumit;
- Maddocks, Kami;
- Freedman, Arnold;
- Weitman, Steven;
- Zucca, Emanuele;
- Munteanu, Mihaela C.;
- Lia Palomba, M.
Publication type:
Article
Safety and efficacy of polatuzumab vedotin + obinutuzumab for relapsed/refractory non‐Hodgkin lymphomas: A phase IB/II study.
Published in:
American Journal of Hematology, 2022, v. 97, n. 1, p. E24, doi. 10.1002/ajh.26400
By:
- Phillips, Tycel;
- Brunvand, Mark;
- Chen, Andy I.;
- Essell, James;
- Chiappella, Annalisa;
- Diefenbach, Catherine;
- Cheng, Ji;
- Ramies, David;
- Hirata, Jamie;
- Morschhauser, Franck;
- Flinn, Ian W.
Publication type:
Article
A phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed or relapsed/refractory multiple myeloma: Final analysis of second dose‐expansion cohort.
Published in:
American Journal of Hematology, 2021, v. 96, n. 4, p. 428, doi. 10.1002/ajh.26088
By:
- Berdeja, Jesus G.;
- Gregory, Tara K.;
- Faber, Edward A.;
- Hart, Lowell L.;
- Mace, Joseph R.;
- Arrowsmith, Edward R.;
- Flinn, Ian W.;
- Matous, Jeffrey V.
Publication type:
Article
Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study.
Published in:
2021
By:
- Greil, Richard;
- Tedeschi, Alessandra;
- Moreno, Carol;
- Anz, Bertrand;
- Larratt, Loree;
- Simkovic, Martin;
- Gill, Devinder;
- Gribben, John G.;
- Flinn, Ian W.;
- Wang, Zhengyuan;
- Cheung, Leo W. K.;
- Nguyen, Aaron N.;
- Zhou, Cathy;
- Styles, Lori;
- Demirkan, Fatih
Publication type:
journal article
Prospective SPECT-CT Organ Dosimetry-Driven Radiation-Absorbed Dose Escalation Using the In-111 (111 In)/Yttrium 90 (90 Y) Ibritumomab Tiuxetan (Zevalin ®) Theranostic Pair in Patients with Lymphoma at Myeloablative Dose Levels.
Published in:
Cancers, 2021, v. 13, n. 11, p. 2828, doi. 10.3390/cancers13112828
By:
- Wahl, Richard L.;
- Frey, Eric C.;
- Jacene, Heather A.;
- Kahl, Brad S.;
- Piantadosi, Steven;
- Bianco, Jesus A.;
- Hammes, Richard J.;
- Jung, Miah;
- Kasecamp, Wayne;
- He, Bin;
- Sgouros, George;
- Flinn, Ian W.;
- Swinnen, Lode J.
Publication type:
Article
Prognostic information and biological insights in chronic lymphocytic leukemia by high-resolution immunophenotypic analysis of ZAP70.
Published in:
Cytometry. Part A, 2014, v. 85, n. 9, p. 798, doi. 10.1002/cyto.a.22485
By:
- Kaplan, David;
- Sun, Zhuoxin;
- Tallman, Martin S.;
- Flinn, Ian W.;
- Xiao, Wenbin;
- Caimi, Paolo F.;
- Kaye, Nicholas M.;
- Lazarus, Hillard M.
Publication type:
Article
Is There Still a Role for PI3K Inhibitors in CLL?
Published in:
Clinical Advances in Hematology & Oncology, 2023, v. 21, n. 4, p. 192
By:
- Flinn, Ian W.
Publication type:
Article
Rituximab with or without bevacizumab for the treatment of patients with relapsed follicular lymphoma.
Published in:
2014
By:
- Hainsworth, John D;
- Greco, F Anthony;
- Raefsky, Eric L;
- Thompson, Dana S;
- Lunin, Scott;
- Reeves Jr, James;
- White, Lynn;
- Quinn, Raven;
- DeBusk, Laura M;
- Flinn, Ian W
Publication type:
Journal Article
Brief-Duration Rituximab/Chemotherapy Followed by Maintenance Rituximab in Patients With Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy: A Phase II Trial of the Sarah Cannon Oncology Research Consortium.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 1, p. 44, doi. 10.3816/CLML.2010.n.004
By:
- Hainsworth, John D.;
- Flinn, Ian W.;
- Spigel, David R.;
- Clark, Bobby L.;
- Griner, Paula L.;
- Vazquez, Elizabeth R.;
- Doss, Habib H.;
- Shipley, Dianna;
- Franco, Luis A.;
- Burris, III, Howard A.;
- Greco, F. Anthony
Publication type:
Article
Maintenance Therapies in Indolent Lymphomas: should Recent Data Change the Standard of Care?
Published in:
2017
By:
- Tees, Michael;
- Flinn, Ian;
- Tees, Michael T;
- Flinn, Ian W
Publication type:
journal article
MALT Lymphomas.
Published in:
2003
By:
- Malek, Sami;
- Hatfield, Amy;
- Flinn, Ian;
- Malek, Sami N;
- Hatfield, Amy J;
- Flinn, Ian W
Publication type:
journal article
Long-term responses in patients with recurring or refractory B-cell non-Hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetan.
Published in:
2007
By:
- Witzig, Thomas E.;
- Molina, Arturo;
- Gordon, Leo I.;
- Emmanouilides, Christos;
- Schilder, Russell J.;
- Flinn, Ian W.;
- Darif, Mohamed;
- Macklis, Roger;
- Vo, Katie;
- Wiseman, Gregory A.
Publication type:
journal article
Phase II study of single‐agent bortezomib for the treatment of patients with fludarabine‐refractory B‐cell chronic lymphocytic leukemia.
Published in:
Cancer (0008543X), 2006, v. 107, n. 5, p. 916
By:
- Stefan Faderl;
- Kanti Rai;
- John Gribben;
- John C. Byrd;
- Ian W. Flinn;
- Susan O'Brien;
- Shihong Sheng;
- Dixie‐Lee Esseltine;
- Michael J. Keating
Publication type:
Article
Oncology Nursing Experience in Phase 3 iLLUMINATE: First-Line Ibrutinib-Obinutuzumab Versus Chlorambucil-Obinutuzumab for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL).
Published in:
Journal of Oncology Navigation & Survivorship, 2019, v. 10, n. 11, p. 506
By:
- Burtt, Shelbi;
- Scott, Jessica;
- Zhou, Cathy;
- Styles, Lori;
- Arthur, David;
- Anz, Bertrand;
- Flinn, Ian W.
Publication type:
Article
CLL-139: Acalabrutinib ± Obinutuzumab vs Obinutuzumab + Chlorambucil in Treatment-Naïve Chronic Lymphocytic Leukemia: ELEVATE-TN 4-Year Follow-up.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S318, doi. 10.1016/S2152-2650(21)01751-1
By:
- Sharman, Jeff P.;
- Egyed, Miklos;
- Jurczak, Wojciech;
- Skarbnik, Alan;
- Pagel, John M.;
- Flinn, Ian W.;
- Kamdar, Manali;
- Munir, Talha;
- Walewska, Renata;
- Corbett, Gillian;
- Fogliatto, Laura Maria;
- Herishanu, Yair;
- Banerji, Versha;
- Coutre, Steven;
- Follows, George;
- Walker, Patricia;
- Karlsson, Karin;
- Ghia, Paolo;
- Janssens, Ann;
- Cymbalista, Florence
Publication type:
Article
Poster: CLL-139: Acalabrutinib ± Obinutuzumab vs Obinutuzumab + Chlorambucil in Treatment-Naïve Chronic Lymphocytic Leukemia: ELEVATE-TN 4-Year Follow-up.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S220, doi. 10.1016/S2152-2650(21)01390-2
By:
- Sharman, Jeff P.;
- Egyed, Miklos;
- Jurczak, Wojciech;
- Skarbnik, Alan;
- Pagel, John M.;
- Flinn, Ian W.;
- Kamdar, Manali;
- Munir, Talha;
- Walewska, Renata;
- Corbett, Gillian;
- Fogliatto, Laura Maria;
- Yair Herishanu;
- Banerji, Versha;
- Coutre, Steven;
- Follows, George;
- Walker, Patricia;
- Karlsson, Karin;
- Ghia, Paolo;
- Janssens, Ann;
- Cymbalista, Florence
Publication type:
Article
Differences in Quality of Life Between Bendamustine-Rituximab and R-CHOP/R-CVP in Patients With Previously Untreated Advanced Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma.
Published in:
2016
By:
- Burke, John M.;
- van der Jagt, Richard H.C.;
- Kahl, Brad S.;
- Wood, Peter;
- Hawkins, Tim E.;
- MacDonald, David;
- Hertzberg, Mark;
- Simpson, David;
- Craig, Michael;
- Kolibaba, Kathryn;
- Issa, Samar;
- Munteanu, Mihaela;
- Victor, Timothy W.;
- Flinn, Ian W.
Publication type:
journal article
A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin’s lymphoma.
Published in:
Annals of Hematology, 2006, v. 85, n. 5, p. 301, doi. 10.1007/s00277-005-0025-9
By:
- Waselenko, Jamie K.;
- Reese, Amy;
- Park, Kathy;
- Lucas, Margaret;
- Goodrich, Amy;
- Willis, Carl R.;
- Diehl, Louis F.;
- Grever, Michael R.;
- Byrd, John C.;
- Flinn, Ian W.
Publication type:
Article
SEQUOIA: results of a phase 3 randomized study of Zanubrutinib versus Bendamustine + Rituximab (BR) in patients with treatment-naive chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).
Published in:
Acta Haematologica Polonica, 2022, v. 53, n. A, p. 32
By:
- Robak, Tadeusz;
- Giannopoulos, Krzysztof;
- Jurczak, Wojciech;
- Šimkovič, Martin;
- Shadman, Mazyar;
- Österborg, Anders;
- Laurenti, Luca;
- Walker, Patricia;
- Opat, Stephen;
- Chan, Henry;
- Ciepluch, Hanna;
- Greil, Richard;
- Tani, Monica;
- Trněný, Marek;
- Brander, Danielle M.;
- Flinn, Ian W.;
- Grosicki, Sebastian;
- Verner, Emma;
- Kahl, Brad S.;
- Ghia, Paolo
Publication type:
Article
Primary results from the double-blind, placebo-controlled, phase 3 SHINE study of ibrutinib in combination with bendamustine-rituximab (BR) and R maintenance as a first-line treatment for older patients with mantle cell lymphoma (MCL).
Published in:
Acta Haematologica Polonica, 2022, v. 53, n. A, p. 42
By:
- Jurczak, Wojciech;
- Gouill, Steven Le;
- Jerkeman, Mats;
- Trotman, Judith;
- Zinzani, Pier Luigi;
- Belada, David;
- Boccomini, Carola;
- Flinn, Ian W.;
- Giri, Pratyush;
- Goy, Andre;
- Hamlin, Paul A.;
- Hermine, Olivier;
- Hernández-Rivas, José-ángel;
- Xiaonan Hong;
- Seok Jin Kim;
- Lewis, David;
- Yuko Mishima;
- Özcan, Muhit;
- Perini, Guilherme Fleury;
- Pocock, Christopher
Publication type:
Article
Combination trial of duvelisib (IPI‐145) with rituximab or bendamustine/rituximab in patients with non‐Hodgkin lymphoma or chronic lymphocytic leukemia.
Published in:
American Journal of Hematology, 2019, v. 94, n. 12, p. 1325, doi. 10.1002/ajh.25634
By:
- Flinn, Ian W.;
- Cherry, Mohamad A.;
- Maris, Michael B.;
- Matous, Jeffrey V.;
- Berdeja, Jesus G.;
- Patel, Manish
Publication type:
Article
Efficacy and safety of the dual SYK/JAK inhibitor cerdulatinib in patients with relapsed or refractory B‐cell malignancies: Results of a phase I study.
Published in:
American Journal of Hematology, 2019, v. 94, n. 4, p. E90, doi. 10.1002/ajh.25387
By:
- Hamlin, Paul A.;
- Flinn, Ian W.;
- Wagner‐Johnston, Nina;
- Burger, Jan A.;
- Coffey, Greg P.;
- Conley, Pamela B.;
- Michelson, Glenn;
- Leeds, Janet M.;
- Der, Kenneth;
- Kim, Yvonne;
- Sabalvaro‐Torres, Alice;
- Birrell, Matt;
- Pandey, Anjali;
- Curnutte, John T.;
- Patel, Manish R.
Publication type:
Article
Single‐agent ibrutinib versus chemoimmunotherapy regimens for treatment‐naïve patients with chronic lymphocytic leukemia: A cross‐trial comparison of phase 3 studies.
Published in:
American Journal of Hematology, 2018, v. 93, n. 11, p. 1402, doi. 10.1002/ajh.25259
By:
- Robak, Tadeusz;
- Burger, Jan A.;
- Tedeschi, Alessandra;
- Barr, Paul M.;
- Owen, Carolyn;
- Bairey, Osnat;
- Hillmen, Peter;
- Simpson, David;
- Grosicki, Sebastian;
- Devereux, Stephen;
- McCarthy, Helen;
- Coutre, Steven E.;
- Quach, Hang;
- Gaidano, Gianluca;
- Maslyak, Zvenyslava;
- Stevens, Don A.;
- Moreno, Carol;
- Gill, Devinder S.;
- Flinn, Ian W.;
- Gribben, John G.
Publication type:
Article
Duvelisib, an oral dual PI3K‐δ, γ inhibitor, shows clinical activity in indolent non‐Hodgkin lymphoma in a phase 1 study.
Published in:
American Journal of Hematology, 2018, v. 93, n. 11, p. 1311, doi. 10.1002/ajh.25228
By:
- Flinn, Ian W.;
- Patel, Manish;
- Oki, Yasuhiro;
- Horwitz, Steven;
- Foss, Francine F.;
- Allen, Kerstin;
- Douglas, Mark;
- Stern, Howard;
- Sweeney, Jennifer;
- Kharidia, Jahnavi;
- Kelly, Patrick;
- Kelly, Virginia M.;
- Kahl, Brad
Publication type:
Article
A phase II study of two dose levels of ofatumumab induction followed by maintenance therapy in symptomatic, previously untreated chronic lymphocytic leukemia.
Published in:
American Journal of Hematology, 2016, v. 91, n. 10, p. 1020, doi. 10.1002/ajh.24468
By:
- Flinn, Ian W.;
- Ruppert, Amy S.;
- Harwin, William;
- Waterhouse, David;
- Papish, Steven;
- Jones, Jeffrey A.;
- Hainsworth, John;
- Byrd, John C.
Publication type:
Article
A phase 2, multicenter study investigating ofatumumab and bendamustine combination in patients with untreated or relapsed CLL.
Published in:
American Journal of Hematology, 2016, v. 91, n. 9, p. 900, doi. 10.1002/ajh.24430
By:
- Flinn, Ian W.;
- Panayiotidis, Panayiotis;
- Afanasyev, Boris;
- Janssens, Ann;
- Grosicki, Sebastian;
- Homenda, Wojciech;
- Smolej, Lukas;
- Kuliczkowski, Kazimierz;
- Doubek, Michael;
- Domnikova, Natalia;
- West, Sarah L.;
- Chang, Chai-Ni;
- Barker, Alison M.;
- Gupta, Ira V.;
- Wright, Oliver J.;
- Offner, Fritz
Publication type:
Article
Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acid.
Published in:
American Journal of Hematology, 2011, v. 86, n. 1, p. 25, doi. 10.1002/ajh.21912
By:
- Berenson, James R.;
- Yellin, Ori;
- Crowley, John;
- Makary, Adel;
- Gravenor, Donald S.;
- Yang, Hank H.;
- Upadhyaya, Gargi H.;
- Flinn, Ian W.;
- Staszewski, Harry;
- Tiffany, Natasha M.;
- Sanani, Shamel;
- Farber, Charles M.;
- Morganstein, Neil;
- Bolejack, Vanessa;
- Nassir, Youram;
- Hilger, James D.;
- Sefaradi, Ashkan;
- Shamouelian, Albert;
- Swift, Regina A.
Publication type:
Article
Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purging for acute myeloid leukaemia beyond first remission: a 10-year experience.
Published in:
British Journal of Haematology, 2002, v. 117, n. 4, p. 907, doi. 10.1046/j.1365-2141.2002.03530.x
By:
- Smith, B. Douglas;
- Jones, Richard J;
- Lee, Shing M;
- Piantadosi, Steve;
- Vala, Milada S;
- Fuller, Don;
- Gore, Steven D;
- Noga, Steven J;
- O'Donnell, Paul V;
- Braine, Hayden;
- Vogelsang, Georgia B;
- Fuchs, Ephraim J;
- Flinn, Ian W;
- Brodsky, Robert A;
- Ambinder, Richard F;
- Miller, Carole B
Publication type:
Article
Phase II Study of Bendamustine and Ofatumumab in Elderly Patients with Newly Diagnosed Diffuse Large B‐Cell Lymphoma Who Are Poor Candidates for R‐CHOP Chemotherapy.
Published in:
Oncologist, 2019, v. 24, n. 8, p. 1035, doi. 10.1634/theoncologist.2019-0286
By:
- Flinn, Ian W.;
- Erter, Jack;
- Daniel, Davey B.;
- Mace, Joseph R.;
- Berdeja, Jesus G.
Publication type:
Article
A Phase II Trial Evaluating the Safety of Rapid Infusion of Ofatumumab in Patients with Previously Treated Chronic Lymphocytic Leukemia.
Published in:
Oncologist, 2017, v. 22, n. 10, p. 1156, doi. 10.1634/theoncologist.2017-0236
By:
- Donnellan, William;
- Berdeja, Jesus G.;
- Shipley, Diana;
- Arrowsmith, Edward R.;
- Wright, David;
- Lunin, Scott;
- Brown, Richard;
- Essell, James H.;
- Flinn, Ian W.
Publication type:
Article
Evaluation of bleeding risk in patients who received pirtobrutinib in the presence or absence of antithrombotic therapy.
Published in:
EJHaem, 2024, v. 5, n. 5, p. 929, doi. 10.1002/jha2.1013
By:
- Lamanna, Nicole;
- Tam, Constantine S.;
- Woyach, Jennifer A.;
- Alencar, Alvaro J.;
- Palomba, M. Lia;
- Zinzani, Pier Luigi;
- Flinn, Ian W.;
- Fakhri, Bita;
- Cohen, Jonathon B.;
- Kontos, Arrin;
- Konig, Heiko;
- Ruppert, Amy S.;
- Chatterjee, Anindya;
- Sizelove, Richard;
- Compte, Livia;
- Tsai, Donald E.;
- Jurczak, Wojciech
Publication type:
Article
Phase Ib study of avadomide (CC‐122) in combination with rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma and follicular lymphoma.
Published in:
EJHaem, 2022, v. 3, n. 2, p. 394, doi. 10.1002/jha2.394
By:
- Nastoupil, Loretta J.;
- Kuruvilla, John;
- Chavez, Julio C.;
- Bijou, Fontanet;
- Witzig, Thomas E.;
- Santoro, Armando;
- Flinn, Ian W.;
- Boccomini, Carola;
- Kenkre, Vaishalee P.;
- Corradini, Paolo;
- Isufi, Iris;
- Andorsky, David J.;
- Klein, Leonard M.;
- Greenwald, Daniel R.;
- Sangha, Randeep;
- Shen, Frank;
- Hagner, Patrick;
- Li, Yan;
- Dobmeyer, Juergen;
- Gong, Nian
Publication type:
Article
Phase Ib study of combinations of avadomide (CC‐122), CC‐223, CC‐292, and rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma.
Published in:
EJHaem, 2022, v. 3, n. 1, p. 139, doi. 10.1002/jha2.375
By:
- Ribrag, Vincent;
- Chavez, Julio C.;
- Boccomini, Carola;
- Kaplan, Jason;
- Chandler, Jason C.;
- Santoro, Armando;
- Corradini, Paolo;
- Flinn, Ian W.;
- Advani, Ranjana;
- Cassier, Philippe A.;
- Sangha, Randeep;
- Kenkre, Vaishalee P.;
- Isufi, Iris;
- Uttamsingh, Shailaja;
- Hagner, Patrick R.;
- Gandhi, Anita K.;
- Shen, Frank;
- Michelliza, Sophie;
- Haeske, Harald;
- Hege, Kristen
Publication type:
Article

Found: 41